— 
| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 500mg | 20 pill | NZD53.54 | NZD1,188.76 NZD1,069.88 Best Price Popular | |
| 500mg | 10 pill | NZD66.89 | NZD744.30 NZD669.87 |
Xeloda, known generically as capecitabine, is an oral chemotherapy medication frequently prescribed to treat various types of cancer. It is used in New Zealand primarily for managing breast, colorectal, and gastric cancers. The convenience of taking Xeloda in tablet form makes it a popular choice among patients who prefer to avoid frequent hospital visits for infusions. This medication works by converting into 5-fluorouracil (5-FU) once inside the body, targeting and destroying cancer cells effectively.
Capecitabine is a prodrug that undergoes enzymatic activation within the body. After ingestion, it is absorbed through the gastrointestinal tract and transported to the tumour tissues where it transforms into 5-FU. This active compound interferes with the DNA synthesis of rapidly dividing cancer cells, inhibiting their growth and replication. Due to its targeted action, Xeloda has shown promising results in improving survival rates and reducing tumour size in various cancers.
For patients in New Zealand, Xeloda is typically prescribed as a twice-daily dose, taken at approximately 12-hour intervals, with food to minimise gastrointestinal discomfort. The exact dosage and duration depend on the specific condition being treated, overall health, and response to therapy. It is essential to follow the healthcare provider’s instructions precisely. Regular monitoring, including blood tests, is advised to track any potential side effects and ensure the medication's effectiveness.
Like all chemotherapy drugs, Xeloda can cause side effects. Common reactions include nausea, diarrhea, hand-foot syndrome (redness, swelling, and pain on palms and soles), and fatigue. Some patients in New Zealand have reported mild to moderate skin reactions, which can often be managed with supportive care. Severe side effects, although rare, such as blood abnormalities or liver toxicity, require immediate medical attention. It is important to communicate any adverse symptoms to healthcare providers promptly.
Many patients in New Zealand who have taken Xeloda have expressed appreciation for its ease of use. The oral administration allows flexibility, and most find it more convenient than hospital-based infusions. Some reviews highlight the importance of adhering strictly to the prescribed schedule to minimise side effects and optimise outcomes. A few users have noted tolerable manageable discomforts, especially when taking preventive measures advised by their doctors. Overall, patients report that, while challenging at times, Xeloda provides a vital treatment option that can be integrated into daily life with proper support.
Xeloda is available through licensed pharmacies in New Zealand. It is generally covered under the public health system for eligible patients, but costs may vary depending on insurance and specific pharmacy policies. Many patients opt to purchase Xeloda through trusted online pharmacies that comply with local regulations, ensuring the medication's authenticity and safety. Always consult with a healthcare professional before obtaining and starting this medication to ensure it suits your specific medical needs.
14–21 days. Free from NZD347.22 .
5–9 days. NZD52.08
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
